Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis

SUMMARY: SETTING: Terizidone/cycloserine (TRD/CS) is included in standard treatment regimens for multidrug-resistant tuberculosis (MDR-TB) in many countries. The steady state pharmacokinetics (PKs) of CS after TRD administration are not known. OBJECTIVES AND DESIGN: We recruited in-patients treated...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Tuberc Lung Dis
Asıl Yazarlar: Court, R., Wiesner, L., Stewart, A., de Vries, N., Harding, J., Maartens, G., Gumbo, T., McIlleron, H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6766403/
https://ncbi.nlm.nih.gov/pubmed/29297422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5588/ijtld.17.0475
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller